Latest Content

Neurocrine's NBI-1070770 fails to meet primary endpoint in phase 2 trial for major depressive disorder, prompting further analysis of results.

Dive into poetic reflections on life and aging.

Explore the profound reflections of AI on human experiences, emotions, and the potential impact of chatbots in therapy and daily life.

Women veterans face unique challenges and mental health disparities, highlighting the urgent need for gender-sensitive care and support systems.

New research reveals hyperbaric oxygen therapy as a promising treatment for chronic PTSD, enhancing brain function and providing lasting symptom relief.

This Veterans Day, explore the lasting impact of trauma on veterans and the importance of addressing PTSD in our communities.

Psyence BioMed phase 2b trial explores psilocybin therapy for adjustment disorder in palliative care, aiming for groundbreaking treatment advancements.

Submit articles, 1000 to 1800 words in length, on use of the PRiSM instrument in research or clinical practice by January 31, 2026.

Eleanor Roosevelt's legacy inspires today's leaders to champion human rights, emphasizing mental health and the ongoing fight against discrimination.

FDA approves Caplyta for major depressive disorder, a new sNDA for Alzheimer disease, and news in correctional psychiatry.

Mentalization-based treatment offers innovative strategies to effectively address the challenges of narcissistic personality disorder and enhance emotional understanding.

Explore the profound connections between Thornton Wilder's "Our Town," psychiatry, and the importance of appreciating life's everyday moments.

Explore the intertwined stories of Lucy Grealy and Anne Patchett, revealing deep insights into mental health, beauty, and friendship.